PG · PROCTER & GAMBLE Co · Documents
$161.02
-4.57 (-2.76%)
At close · Oct 23
Ex-dividend: $1.0885 · Oct 23, 2026
Return incl. dividend (before tax)
-2.10%
Market Cap
$373.21B
Shares
2.32B
Volume · Oct 23
10.35M
Avg daily vol (3M)
9.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Procter & Gamble reported fiscal year 2027 first-quarter net sales of $23.3 billion, up 4.0%, diluted EPS of $1.97 and core EPS of $2.00. Fiscal 2027 organic sales growth guidance remained one to three percent. | 2026-10-22 | — | |
| 10-Q | P&G reported net sales of $23.3 billion, up 4.0%, and diluted EPS of $1.97 and Core EPS of $2.00, both up 1%. It completed the $3.9 billion Thorne acquisition on October 1, 2026. | 2026-10-22 | 2026-09-30 | |
| 8-K | The Procter & Gamble Company reported first-quarter organic sales growth of +4.0% and core EPS growth of 1%. Guidance calls for organic sales growth of +1% to +3% and core EPS growth of +0% to +3%. | 2026-10-22 | — | |
| 8-K | Procter & Gamble held its 2026 Annual Meeting on October 13, 2026, where all twelve director nominees were elected, the auditor appointment was ratified, and Say on Pay was approved, while three shareholder proposals were not approved. | 2026-10-16 | — | |
| S-3ASR | Procter & Gamble may sell debt securities from time to time in one or more offerings, directly or through agents, underwriters or dealers; net proceeds will generally fund general corporate purposes. | 2026-10-15 | — | |
| S-3ASR | The Procter & Gamble Company registers 8,000,000 shares of common stock for its Direct Stock Purchase Plan, enabling participants to purchase shares and reinvest dividends. Equiniti Trust Company, LLC administers the Plan, which pays P&G no proceeds. | 2026-10-15 | — | |
| S-3ASR | On October 15, 2026, The Procter & Gamble Company registered 100,000 shares of common stock for participants in The Procter & Gamble Limited Share Investment Scheme, a voluntary direct purchase plan for eligible UK employees and P&G UK retirees. | 2026-10-15 | — | |
| 8-K | Procter & Gamble declared a quarterly dividend of $1.0885 per share, payable on or after November 16, 2026, and shareholders preliminarily elected all 12 director nominees at its 2026 Annual Meeting. | 2026-10-13 | — | |
| Investor Event Transcript | At Procter & Gamble Company's 2026 Annual Meeting, shareholders elected all director nominees, ratified Deloitte & Touche LLP and executive compensation, rejected three shareholder proposals, and declared a quarterly dividend of $1.0885 per share payable on or after November 16, 2026. | 2026-10-13 | 2026-06-30 | |
| DEFA14A | P&G reaffirmed its recommendation that shareholders vote AGAINST Item 5, citing uncertainty surrounding the SEC’s September 16, 2026 proposal to rescind Rule 14a-8, and affirmed that the company will continue complying while the rule remains binding. | 2026-10-07 | — | |
| DEF 14A | — | 2026-08-28 | 2026-10-13 | |
| DEFA14A | — | 2026-08-28 | — | |
| ARS | — | 2026-08-28 | 2026-06-30 | |
| 10-K | — | 2026-08-04 | 2026-06-30 | |
| 8-K | — | 2026-07-29 | — | |
| 8-K | — | 2026-07-29 | — | |
| 8-K | — | 2026-07-29 | — | |
| 8-K | — | 2026-07-14 | — | |
| Investor Event Transcript | — | 2026-06-10 | 2025-12-31 | |
| Investor Event Transcript | — | 2026-06-03 | 2025-12-31 | |
| Investor Event Transcript | — | 2026-06-03 | 2025-12-31 | |
| 8-K | — | 2026-04-24 | — | |
| 10-Q | — | 2026-04-24 | 2026-03-31 | |
| 8-K | — | 2026-04-24 | — | |
| 8-K | — | 2026-04-14 | — | |
| Investor Event Transcript | — | 2026-02-19 | 2025-09-30 | |
| 10-Q | — | 2026-01-23 | 2025-12-31 | |
| 8-K | — | 2026-01-22 | — | |
| 8-K | — | 2026-01-22 | — | |
| 8-K | — | 2026-01-13 | — | |
| 8-K | — | 2025-12-15 | — | |
| 8-K | — | 2025-11-04 | — | |
| 8-K | — | 2025-11-03 | — | |
| 8-K | — | 2025-10-24 | — | |
| 8-K | — | 2025-10-24 | — | |
| 10-Q | — | 2025-10-24 | 2025-09-30 | |
| 8-K | — | 2025-10-16 | — | |
| 8-K | — | 2025-10-14 | — | |
| DEF 14A | — | 2025-08-29 | 2025-10-14 | |
| ARS | — | 2025-08-29 | 2025-06-30 | |
| DEFA14A | — | 2025-08-29 | — | |
| 8-K | — | 2025-08-14 | — | |
| 10-K | — | 2025-08-04 | 2025-06-30 | |
| 8-K | — | 2025-07-29 | — | |
| 8-K | — | 2025-07-29 | — | |
| 8-K | — | 2025-07-28 | — | |
| 8-K | — | 2025-07-08 | — | |
| 8-K | — | 2025-06-09 | — | |
| 8-K | — | 2025-06-05 | — | |
| 8-K | — | 2025-05-01 | — |
Showing 1–50 of 202 filings
Key facts
CIK
80424
CUSIP
742718109
13F (30d)
1371 filings
1332 filers
Visit website
Investor relations